CSIR Central

Engineered Nanocrystal Technology: in-vivo fate, targeting and applications in drug delivery

IR@CDRI: CSIR-Central Drug Research Institute, Lucknow

View Archive Info
 
 
Field Value
 
Creator Pawar, V K
Singh, Yuvraj
Meher, J G
Gupta, Siddharth
Chourasia, M K
 
Date 2014-08-11T05:51:17Z
2014-08-11T05:51:17Z
2014
 
Identifier Journal of Controlled Release. 2014, 183, 51-66
http://hdl.handle.net/123456789/1349
 
Description Formulation of nanocrystals is a robust approach which can improve delivery of poorly water soluble drugs, a challenge pharmaceutical industry has been facing since long. Large scale production of nanocrystals is done by techniques like precipitation, media milling and, high pressure homogenization. Application of stabilizers along with drying accords nanocrystals long term stability and commercial viability. These can be administered through oral, parenteral, pulmonary, dermal and ocular routes showing their high therapeutic applicability. They serve to target drug molecules in specific regions through size manipulation and surface modification. This review dwells upon the in-vivo fate and varying applications in addition to the facets of drug nanocrystals stated above.
 
Format 882789 bytes
application/pdf
 
Language en
 
Relation CSIR-CDRI Communication No. 8640
 
Subject Nanocrystals
Poorly Soluble Drugs
In-Vivo Fate
Bioavailability
Stability
Targeted Delivery
 
Title Engineered Nanocrystal Technology: in-vivo fate, targeting and applications in drug delivery
 
Type Article